MTOR and breast carcinoma: This signalling pathway leading through AMPK activation to mTOR inhibition is thought to be, at least partly, responsible for both suppression of the proliferation and inhibition of the cell cycle in G1 phase as well as induction of apoptosis in breast cancer cells [47].